9th Microbiome Movement Drug Development Summit
Evvnt Promotion / evvnt
Archivo
10.07.2024 - 12.07.2024 The Westin Copley Place, Boston, 10 Huntington Avenue, 02116 Boston, Massachusetts, USA
Time: 8:30 AM - 4:15 PM
Temas de la conferencia
As landmark Ferring and Seres Therapeutics approvals prove the safety of the microbiome modality, robust clinical efficacy data for disease beyond infectious is now paramount to reinvigorate investment across the community.
The 9th Microbiome Movement Drug Development Summit returns as the industry's trusted, definitive forum for the global network of microbial therapeutic developers.
As landmark Ferring and Seres Therapeutics approvals prove the safety of the microbiome modality, robust clinical efficacy data for disease beyond infectious is now paramount to reinvigorate investment across the community.
The 9th Microbiome Movement Drug Development Summit returns as the industry's trusted, definitive forum for the global network of microbial therapeutic developers.
Organizador profesional (PCO)
Hanson Wade
Hanson Wade
Observaciones
URL:
Brochure: https://go.evvnt.com/2317343-3?pid=4832
Speakers: Ada Lam, Research Analyst, Beacon Microbiome, Adam Harvey, Associate Director - Clinical Research, Global Clinical and Translational Sciences, Ferring Pharmaceuticals, and more
URL:
Brochure: https://go.evvnt.com/2317343-3?pid=4832
Speakers: Ada Lam, Research Analyst, Beacon Microbiome, Adam Harvey, Associate Director - Clinical Research, Global Clinical and Translational Sciences, Ferring Pharmaceuticals, and more
Información e inscripción:
https://go.evvnt.com/2317343-2?pid=4832
Ms. Nandita Iyer
Medicina General
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
